Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Altar

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Comparative Neurology|June 26, 1995
Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptorsK D Anderson, R F Alderson, C A Altar, et al.
Journal of Neurochemistry|December 1, 1992
Recovery of cholinergic phenotype in the injured rat neostriatum: roles for endogenous and exogenous nerve growth factorC A Altar, M Armanini, M Dugich-Djordjevic, et al.
Nature|February 12, 1998
Anterograde transport of brain-derived neurotrophic factor and its role in the brainC A Altar, N Cai, T Bliven, et al.
Journal of Neurochemistry|September 1, 1994
Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesionsC A Altar, C B Boylan, M Fritsche, et al.
Brain Research|February 19, 1996
A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effectsB E Jones, C B Boylan, M Fritsche, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1993
Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transectionJ K Morse, S J Wiegand, K Anderson, et al.
Clinical Pharmacology and Therapeutics|December 20, 2007
A prototypical process for creating evidentiary standards for biomarkers and diagnosticsC A Altar, D Amakye, D Bounos, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Comparative Neurology|June 26, 1995
Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptorsK D Anderson, R F Alderson, C A Altar, et al.
Journal of Neurochemistry|December 1, 1992
Recovery of cholinergic phenotype in the injured rat neostriatum: roles for endogenous and exogenous nerve growth factorC A Altar, M Armanini, M Dugich-Djordjevic, et al.
Nature|February 12, 1998
Anterograde transport of brain-derived neurotrophic factor and its role in the brainC A Altar, N Cai, T Bliven, et al.
Journal of Neurochemistry|September 1, 1994
Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesionsC A Altar, C B Boylan, M Fritsche, et al.
Brain Research|February 19, 1996
A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effectsB E Jones, C B Boylan, M Fritsche, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1993
Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transectionJ K Morse, S J Wiegand, K Anderson, et al.
Clinical Pharmacology and Therapeutics|December 20, 2007
A prototypical process for creating evidentiary standards for biomarkers and diagnosticsC A Altar, D Amakye, D Bounos, et al.
Pageof 9